Literature DB >> 21293322

Maintenance of IKKβ activity is necessary to protect lung grafts from acute injury.

Howard J Huang1, Seiichiro Sugimoto, Jiaming Lai, Mikio Okazaki, Sumiharu Yamamoto, Alexander S Krupnick, Daniel Kreisel, Andrew E Gelman.   

Abstract

BACKGROUND: Signaling pathways that target I-κB kinase β (IKKβ) activation stimulate the expression of nuclear factor (NF)-κB-dependent genes and are thus believed to primarily promote inflammation and injury in solid organ grafts.
METHODS: We examined the role of IKKβ in a mouse model of lung transplantation-mediated ischemia-reperfusion injury using NF-κB essential modulator (NEMO)-binding domain (NBD) peptide to pharmacologically inhibit IKK activation. As myeloid cells are primarily responsible for the production of acute inflammatory mediators after lung transplantation, we also investigated the effects of myeloid cell-specific IKKβ gene deletion on acute lung graft injury by transplanting mutant mice.
RESULTS: When NBD was administered at a dose that partially inhibits IKKβ activation, we observed attenuated lung graft injury and blunted expression of intragraft proinflammatory mediators. Surprisingly, when the dose of NBD was increased to a level that ablates intragraft IKKβ activation, graft inflammation, and injury were significantly worse compared with recipients treated with control peptide. Similar to lung recipients with pharmacologically ablated IKKβ activity, donor-recipient transplant combinations with a myeloid cell-specific IKKβ gene deletion had marked intragraft inflammation and poor lung function.
CONCLUSIONS: Our data show maintenance of IKKβ activity is critical for promoting graft homeostasis with important implications for targeting NF-κB-dependent signaling pathways for treating acute lung injury.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21293322      PMCID: PMC4020590          DOI: 10.1097/TP.0b013e31820ba2a0

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  37 in total

1.  Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway.

Authors:  U Senftleben; Y Cao; G Xiao; F R Greten; G Krähn; G Bonizzi; Y Chen; Y Hu; A Fong; S C Sun; M Karin
Journal:  Science       Date:  2001-08-24       Impact factor: 47.728

Review 2.  The IKK NF-kappa B system: a treasure trove for drug development.

Authors:  Michael Karin; Yumi Yamamoto; Q May Wang
Journal:  Nat Rev Drug Discov       Date:  2004-01       Impact factor: 84.694

3.  Reperfusion-induced gene expression profiles in rat lung transplantation.

Authors:  Masaomi Yamane; Mingyao Liu; Hiroyuki Kaneda; Stefan Uhlig; Thomas K Waddell; Shaf Keshavjee
Journal:  Am J Transplant       Date:  2005-09       Impact factor: 8.086

4.  IKK beta is required for peripheral B cell survival and proliferation.

Authors:  Zhi-Wei Li; Sidne A Omori; Tord Labuda; Michael Karin; Robert C Rickert
Journal:  J Immunol       Date:  2003-05-01       Impact factor: 5.422

5.  Regulation of lung injury and repair by Toll-like receptors and hyaluronan.

Authors:  Dianhua Jiang; Jiurong Liang; Juan Fan; Shuang Yu; Suping Chen; Yi Luo; Glenn D Prestwich; Marcella M Mascarenhas; Hari G Garg; Deborah A Quinn; Robert J Homer; Daniel R Goldstein; Richard Bucala; Patty J Lee; Ruslan Medzhitov; Paul W Noble
Journal:  Nat Med       Date:  2005-10-23       Impact factor: 53.440

Review 6.  The anti-death machinery in IKK/NF-kappaB signaling.

Authors:  Jun-Li Luo; Hideaki Kamata; Michael Karin
Journal:  J Clin Immunol       Date:  2005-11       Impact factor: 8.317

7.  Allergen-induced peribronchial fibrosis and mucus production mediated by IkappaB kinase beta-dependent genes in airway epithelium.

Authors:  David H Broide; Toby Lawrence; Taylor Doherty; Jae Youn Cho; Marina Miller; Kirsti McElwain; Shauna McElwain; Michael Karin
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-29       Impact factor: 11.205

8.  The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis.

Authors:  Simon Dai; Teruhisa Hirayama; Sabiha Abbas; Yousef Abu-Amer
Journal:  J Biol Chem       Date:  2004-07-13       Impact factor: 5.157

9.  The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion.

Authors:  Lee-Wei Chen; Laurence Egan; Zhi-Wei Li; Florian R Greten; Martin F Kagnoff; Michael Karin
Journal:  Nat Med       Date:  2003-04-07       Impact factor: 53.440

10.  Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo.

Authors:  Eijiro Jimi; Kazuhiro Aoki; Hiroaki Saito; Fulvio D'Acquisto; Michael J May; Ichiro Nakamura; Testuo Sudo; Takefumi Kojima; Fujio Okamoto; Hidefumi Fukushima; Koji Okabe; Keiichi Ohya; Sankar Ghosh
Journal:  Nat Med       Date:  2004-05-23       Impact factor: 53.440

View more
  7 in total

1.  Five-year update on the mouse model of orthotopic lung transplantation: Scientific uses, tricks of the trade, and tips for success.

Authors:  Xue Lin; Wenjun Li; Jiaming Lai; Mikio Okazaki; Seiichiro Sugimoto; Sumiharu Yamamoto; Xingan Wang; Andrew E Gelman; Daniel Kreisel; Alexander Sasha Krupnick
Journal:  J Thorac Dis       Date:  2012-06-01       Impact factor: 2.895

2.  Conditional and specific inhibition of NF-κB in mouse pancreatic β cells prevents cytokine-induced deleterious effects and improves islet survival posttransplant.

Authors:  Jonathan S Rink; Xiaojuan Chen; Xiaomin Zhang; Dixon B Kaufman
Journal:  Surgery       Date:  2011-10-06       Impact factor: 3.982

3.  Neutrophil-Derived IL-1β Impairs the Efficacy of NF-κB Inhibitors against Lung Cancer.

Authors:  Allyson G McLoed; Taylor P Sherrill; Dong-Sheng Cheng; Wei Han; Jamie A Saxon; Linda A Gleaves; Pingsheng Wu; Vasiliy V Polosukhin; Michael Karin; Fiona E Yull; Georgios T Stathopoulos; Vassilis Georgoulias; Rinat Zaynagetdinov; Timothy S Blackwell
Journal:  Cell Rep       Date:  2016-06-16       Impact factor: 9.423

Review 4.  Report of the ISHLT Working Group on Primary Lung Graft Dysfunction Part III: Mechanisms: A 2016 Consensus Group Statement of the International Society for Heart and Lung Transplantation.

Authors:  Andrew E Gelman; Andrew J Fisher; Howard J Huang; Maher A Baz; Ciara M Shaver; Thomas M Egan; Micheal S Mulligan
Journal:  J Heart Lung Transplant       Date:  2017-07-24       Impact factor: 10.247

5.  SPECT imaging of lung ischemia-reperfusion injury using [99mTc]cFLFLF for molecular targeting of formyl peptide receptor 1.

Authors:  Eric J Charles; Mahendra D Chordia; Yunge Zhao; Yi Zhang; J Hunter Mehaffey; David K Glover; Julien Dimastromatteo; W Zachary Chancellor; Ashish K Sharma; Irving L Kron; Dongfeng Pan; Victor E Laubach
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-12-04       Impact factor: 5.464

6.  Activation of the nuclear factor-κB pathway during postnatal lung inflammation preserves alveolarization by suppressing macrophage inflammatory protein-2.

Authors:  Yanli Hou; Min Liu; Cristiana Husted; Chihhsin Chen; Kavitha Thiagarajan; Jennifer L Johns; Shailaja P Rao; Cristina M Alvira
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-07-10       Impact factor: 5.464

Review 7.  Nuclear factor-kappa-B signaling in lung development and disease: one pathway, numerous functions.

Authors:  Cristina M Alvira
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2014-03-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.